Atlas Trials

Non-Small Cell Lung Carcinoma (NSCLC)

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Small Cell Lung Carcinoma (NSCLC)

RecordFirmDate
A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases (NCT04460729)Novartis Pharmaceuticals2020-11-11
LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872)University of Florida2020-01-10
Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) (NCT03003962)AstraZeneca2017-01-02
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) (NCT02542293)AstraZeneca2015-11-03
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) (NCT02453282)AstraZeneca2015-07-21
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care (NCT02558998)Abramson Cancer Center at Penn Medicine2015-03-01
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) (NCT02346955)Famewave Ltd.2015-02-01
ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer (NCT00328562)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2003-12-01

Track Non-Small Cell Lung Carcinoma (NSCLC) automatically

Every clearance here is in the API, with alerts when new ones post.